spacer
spacer

PDBsum entry 1ca7

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Cytokine PDB id
1ca7

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
114 a.a. *
Ligands
EN1 ×3
Waters ×18
* Residue conservation analysis
PDB id:
1ca7
Name: Cytokine
Title: Macrophage migration inhibitory factor (mif) with hydroxphenylpyruvate
Structure: Protein (macrophage migration inhibitory factor). Chain: a, b, c. Synonym: mif, glycosylation-inhibiting factor. Engineered: yes. Other_details: complexed with hydroxyphenylpyruvate
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
Biol. unit: Trimer (from PDB file)
Resolution:
2.50Å     R-factor:   0.200     R-free:   0.263
Authors: J.B.Lubetsky,E.Lolis
Key ref:
J.B.Lubetsky et al. (1999). Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity. Biochemistry, 38, 7346-7354. PubMed id: 10353846 DOI: 10.1021/bi990306m
Date:
25-Feb-99     Release date:   30-Jun-99    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
P14174  (MIF_HUMAN) -  Macrophage migration inhibitory factor from Homo sapiens
Seq:
Struc:
115 a.a.
114 a.a.
Key:    Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class 2: E.C.5.3.2.1  - phenylpyruvate tautomerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: 3-phenylpyruvate = enol-phenylpyruvate
3-phenylpyruvate
=
enol-phenylpyruvate
Bound ligand (Het Group name = EN1)
matches with 92.31% similarity
   Enzyme class 3: E.C.5.3.3.12  - L-dopachrome isomerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

      Pathway:
      Reaction: L-dopachrome = 5,6-dihydroxyindole-2-carboxylate
L-dopachrome
Bound ligand (Het Group name = EN1)
matches with 80.00% similarity
= 5,6-dihydroxyindole-2-carboxylate
      Cofactor: Zn(2+)
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1021/bi990306m Biochemistry 38:7346-7354 (1999)
PubMed id: 10353846  
 
 
Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity.
J.B.Lubetsky, M.Swope, C.Dealwis, P.Blake, E.Lolis.
 
  ABSTRACT  
 
Macrophage migration inhibitory factor (MIF) is an important immunoregulatory molecule with a unique ability to suppress the anti-inflammatory effects of glucocorticoids. Although considered a cytokine, MIF possesses a three-dimensional structure and active site similar to those of 4-oxalocrotonate tautomerase and 5-carboxymethyl-2-hydroxymuconate isomerase. Moreover, a number of catalytic activities have been defined for MIF. To gain insight into the role of catalysis in the biological function of MIF, we have begun to characterize the catalytic activities in more detail. Here we report the crystal structure of MIF complexed with p-hydroxyphenylpyruvate, a substrate for the phenylpyruvate tautomerase activity of MIF. The three binding sites for p-hydroxyphenylpyruvate in the MIF trimer lie at the interface between two subunits. The substrate interacts with Pro-1, Lys-32, and Ile-64 from one subunit and Tyr-95 and Asn-97 from an adjacent subunit. Pro-1 is positioned to function as a catalytic base. There is no functional group that polarizes the alpha-carbonyl of the substrate to weaken the adjacent C-H bond. Mutation of Pro-1 to glycine substantially reduces the catalytic activity. The insertion of an alanine between Pro-1 and Met-2 essentially abolishes activity. Structural studies of these mutants define a source of the reduced activity and provide insight into the mechanism of the catalytic reaction.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
21168764 H.Kimura, Y.Sato, Y.Tajima, H.Suzuki, H.Yukitake, T.Imaeda, M.Kajino, H.Oki, M.Takizawa, and S.Tanida (2010).
BTZO-1, a cardioprotective agent, reveals that macrophage migration inhibitory factor regulates ARE-mediated gene expression.
  Chem Biol, 17, 1282-1294.
PDB code: 5b4o
19186177 B.E.Rendon, S.S.Willer, W.Zundel, and R.A.Mitchell (2009).
Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation.
  Exp Mol Pathol, 86, 180-185.  
19090677 G.V.Crichlow, J.B.Lubetsky, L.Leng, R.Bucala, and E.J.Lolis (2009).
Structural and kinetic analyses of macrophage migration inhibitory factor active site interactions.
  Biochemistry, 48, 132-139.
PDB codes: 3ce4 3djh 3dji
19827093 S.E.Dobson, K.D.Augustijn, J.A.Brannigan, C.Schnick, C.J.Janse, E.J.Dodson, A.P.Waters, and A.J.Wilkinson (2009).
The crystal structures of macrophage migration inhibitory factor from Plasmodium falciparum and Plasmodium berghei.
  Protein Sci, 18, 2578-2591.
PDB codes: 2wkb 2wkf
19090668 Z.Cournia, L.Leng, S.Gandavadi, X.Du, R.Bucala, and W.L.Jorgensen (2009).
Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening.
  J Med Chem, 52, 416-424.  
  18523291 D.Kamir, S.Zierow, L.Leng, Y.Cho, Y.Diaz, J.Griffith, C.McDonald, M.Merk, R.A.Mitchell, J.Trent, Y.Chen, Y.K.Kwong, H.Xiong, J.Vermeire, M.Cappello, D.McMahon-Pratt, J.Walker, J.Bernhagen, E.Lolis, and R.Bucala (2008).
A Leishmania ortholog of macrophage migration inhibitory factor modulates host macrophage responses.
  J Immunol, 180, 8250-8261.
PDB code: 3b64
18695941 G.J.Poelarends, V.P.Veetil, and C.P.Whitman (2008).
The chemical versatility of the beta-alpha-beta fold: catalytic promiscuity and divergent evolution in the tautomerase superfamily.
  Cell Mol Life Sci, 65, 3606-3618.  
19076379 W.R.Parrish, M.Gallowitsch-Puerta, C.J.Czura, and K.J.Tracey (2008).
Experimental therapeutic strategies for severe sepsis: mediators and mechanisms.
  Ann N Y Acad Sci, 1144, 210-236.  
17661448 G.J.Poelarends, W.H.Johnson, H.Serrano, and C.P.Whitman (2007).
Phenylpyruvate tautomerase activity of trans-3-chloroacrylic acid dehalogenase: evidence for an enol intermediate in the dehalogenase reaction?
  Biochemistry, 46, 9596-9604.  
17526494 G.V.Crichlow, K.F.Cheng, D.Dabideen, M.Ochani, B.Aljabari, V.A.Pavlov, E.J.Miller, E.Lolis, and Y.Al-Abed (2007).
Alternative chemical modifications reverse the binding orientation of a pharmacophore scaffold in the active site of macrophage migration inhibitory factor.
  J Biol Chem, 282, 23089-23095.
PDB codes: 2ooh 2oow 2ooz
17158894 K.D.Augustijn, R.Kleemann, J.Thompson, T.Kooistra, C.E.Crawford, S.E.Reece, A.Pain, A.H.Siebum, C.J.Janse, and A.P.Waters (2007).
Functional characterization of the Plasmodium falciparum and P. berghei homologues of macrophage migration inhibitory factor.
  Infect Immun, 75, 1116-1128.  
17902707 S.C.Wang, W.H.Johnson, R.M.Czerwinski, S.L.Stamps, and C.P.Whitman (2007).
Kinetic and stereochemical analysis of YwhB, a 4-oxalocrotonate tautomerase homologue in Bacillus subtilis: mechanistic implications for the YwhB- and 4-oxalocrotonate tautomerase-catalyzed reactions.
  Biochemistry, 46, 11919-11929.  
17567581 Y.Cho, B.F.Jones, J.J.Vermeire, L.Leng, L.DiFedele, L.M.Harrison, H.Xiong, Y.K.Kwong, Y.Chen, R.Bucala, E.Lolis, and M.Cappello (2007).
Structural and functional characterization of a secreted hookworm Macrophage Migration Inhibitory Factor (MIF) that interacts with the human MIF receptor CD74.
  J Biol Chem, 282, 23447-23456.
PDB code: 2os5
16628200 E.F.Morand, M.Leech, and J.Bernhagen (2006).
MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis.
  Nat Rev Drug Discov, 5, 399-410.  
16285950 J.M.Wilson, P.L.Coletta, R.J.Cuthbert, N.Scott, K.MacLennan, G.Hawcroft, L.Leng, J.B.Lubetsky, K.K.Jin, E.Lolis, F.Medina, J.A.Brieva, R.Poulsom, A.F.Markham, R.Bucala, and M.A.Hull (2005).
Macrophage migration inhibitory factor promotes intestinal tumorigenesis.
  Gastroenterology, 129, 1485-1503.  
16115028 M.Thiele, and J.Bernhagen (2005).
Link between macrophage migration inhibitory factor and cellular redox regulation.
  Antioxid Redox Signal, 7, 1234-1248.  
16115897 Y.Al-Abed, D.Dabideen, B.Aljabari, A.Valster, D.Messmer, M.Ochani, M.Tanovic, K.Ochani, M.Bacher, F.Nicoletti, C.Metz, V.A.Pavlov, E.J.Miller, and K.J.Tracey (2005).
ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis.
  J Biol Chem, 280, 36541-36544.  
12660987 D.Joseph-McCarthy, B.E.Thomas, M.Belmarsh, D.Moustakas, and J.C.Alvarez (2003).
Pharmacophore-based molecular docking to account for ligand flexibility.
  Proteins, 51, 172-188.  
12660988 D.Joseph-McCarthy, and J.C.Alvarez (2003).
Automated generation of MCSS-derived pharmacophoric DOCK site points for searching multiconformation databases.
  Proteins, 51, 189-202.  
12904813 E.Lolis, and R.Bucala (2003).
Therapeutic approaches to innate immunity: severe sepsis and septic shock.
  Nat Rev Drug Discov, 2, 635-645.  
12667094 E.Lolis, and R.Bucala (2003).
Macrophage migration inhibitory factor.
  Expert Opin Ther Targets, 7, 153-164.  
12740374 I.Potolicchio, L.Santambrogio, and J.L.Strominger (2003).
Molecular interaction and enzymatic activity of macrophage migration inhibitory factor with immunorelevant peptides.
  J Biol Chem, 278, 30889-30895.  
12796500 M.T.Nguyen, J.Beck, H.Lue, H.Fünfzig, R.Kleemann, P.Koolwijk, A.Kapurniotu, and J.Bernhagen (2003).
A 16-residue peptide fragment of macrophage migration inhibitory factor, MIF-(50-65), exhibits redox activity and has MIF-like biological functions.
  J Biol Chem, 278, 33654-33671.  
11782558 J.A.Baugh, and R.Bucala (2002).
Macrophage migration inhibitory factor.
  Crit Care Med, 30, S27-S35.  
11997397 J.B.Lubetsky, A.Dios, J.Han, B.Aljabari, B.Ruzsicska, R.Mitchell, E.Lolis, and Y.Al-Abed (2002).
The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents.
  J Biol Chem, 277, 24976-24982.
PDB code: 1ljt
11773615 P.D.Senter, Y.Al-Abed, C.N.Metz, F.Benigni, R.A.Mitchell, J.Chesney, J.Han, C.G.Gartner, S.D.Nelson, G.J.Todaro, and R.Bucala (2002).
Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites.
  Proc Natl Acad Sci U S A, 99, 144-149.  
12382291 T.A.Soares, R.D.Lins, T.P.Straatsma, and J.M.Briggs (2002).
Internal dynamics and ionization states of the macrophage migration inhibitory factor: comparison between wild-type and mutant forms.
  Biopolymers, 65, 313-323.  
12221083 X.Zang, P.Taylor, J.M.Wang, D.J.Meyer, A.L.Scott, M.D.Walkinshaw, and R.M.Maizels (2002).
Homologues of human macrophage migration inhibitory factor from a parasitic nematode. Gene cloning, protein activity, and crystal structure.
  J Biol Chem, 277, 44261-44267.  
11418568 G.J.Poelarends, R.Saunier, and D.B.Janssen (2001).
trans-3-Chloroacrylic acid dehalogenase from Pseudomonas pavonaceae 170 shares structural and mechanistic similarities with 4-oxalocrotonate tautomerase.
  J Bacteriol, 183, 4269-4277.  
11106430 R.Kleemann, H.Rorsman, E.Rosengren, R.Mischke, N.T.Mai, and J.Bernhagen (2000).
Dissection of the enzymatic and immunologic functions of macrophage migration inhibitory factor. Full immunologic activity of N-terminally truncated mutants.
  Eur J Biochem, 267, 7183-7193.  
10933783 S.L.Stamps, A.B.Taylor, S.C.Wang, M.L.Hackert, and C.P.Whitman (2000).
Mechanism of the phenylpyruvate tautomerase activity of macrophage migration inhibitory factor: properties of the P1G, P1A, Y95F, and N97A mutants.
  Biochemistry, 39, 9671-9678.
PDB code: 1mff
10867710 T.Soares, D.Goodsell, R.Ferreira, A.J.Olson, and J.M.Briggs (2000).
Ionization state and molecular docking studies for the macrophage migration inhibitory factor: the role of lysine 32 in the catalytic mechanism.
  J Mol Recognit, 13, 146-156.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer